ALEXANDREA BROOM: Open Payments
NPI 1003568320 · LAURENS, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 28 payments from 17 companies in 2025. Trend: 2023 $157 · 2024 $99 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $176 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| PFIZER INC. | 3 | $52 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Exact Sciences Corporation | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Lundbeck LLC | 1 | $27 |
Products named: Korlym, PREVNAR 20, INJECTAFER, JARDIANCE, Ozempic, XIFAXAN, BREZTRI, Kerendia.
Industry payments across SC — which companies pay providers there.
